Tag: Europe
-
Cellulosic Biomass Sugars Developer Gains BASF Backing
Renmatix Inc., a developer of biofuel sugars from cellulosic feedstocks in King of Prussia, Pennsylvania, has secured a $50 million investment round led by German chemical manufacturer BASF. The BASF subsidiary, BASF Biorenewable Beteiligungs GmbH, contributed $30 million to the investment round, joined by new and existing investors. Renmatix has devised a technology platform called…
-
Software Speeds Database Sequence Searches
Computational biologists at Ludwig-Maximilians Universität (LMU) in Munich, Germany have developed software that makes possible a new search method to identify proteins in databases with similar genomic sequences. The software that the developers say is faster and can discover twice as many evolutionarily related proteins as previous methods, is described online in the journal Nature…
-
New Methods Proposed for Testing Allergens Without Animals
A doctoral dissertation at University of Gothenburg in Sweden has outlined testing methods for allergenic substances that do not require the use of lab animals. Ph.D. candidate in chemistry Sofia Andersson (pictured right) defended the dissertation in Gothenburg earlier this month, and is working with the university’s business development office to advance the methods to…
-
Algae Protein Electrodes Boost Photosynthesis Process
Researchers from the Swiss research institute Empa, University of Basel in Switzerland, and Argonne National Laboratory near Chicago have developed electrodes made from algal protein that mimic a key process in photosynthesis used to directly generate hydrogen from water. The team describes their findings in the online issue of the journal Advanced Functional Materials (paid…
-
U.S., Russia Implement Patent Cooperation Agreement
The United States Patent and Trademark Office (USPTO) and the Russian Federal Service for Intellectual Property (Rospatent) have implemented an agreement simplifying patent applications involving the two countries. Under the agreement, Rospatent will act as an international searching authority (ISA) and international preliminary examining authority (IPEA) for international applications filed with the USPTO as the…
-
FDA Approves Cardiac Device for Children Awaiting Transplant
The U.S. Food and Drug Administration (FDA) on Friday approved the Excor Pediatric System, a device to support children with heart failure until a donor for a heart transplant can be found. The device is made by Berlin Heart GmbH in Germany and The Woodlands, Texas. The Excor Pediatric System is an external heart pump…
-
European Grant Awarded for Research on Enhanced MRI
A chemistry professor at University of Southampton in the U.K. has received a grant for research on enhanced nuclear magnetic resonance (NMR), a principle underlying magnetic resonance imaging (MRI), widely used in medical diagnostics. Malcolm Levitt and colleagues at Southampton were awarded a four-year, €2.8 million ($US 3.8 million) grant from the European Research Council…
-
Enzyme Developer In-Licenses Synthetic Biology Technology
Novozymes A/S in Bagsvaerd, Denmark has agreed to license genetic engineering technology from MorphoSys AG in Martinsried, Germany for the development of industrial biotechnology products. The multi-year agreement provides Novozymes, a manufacturer of industrial enzymes, with a non-exclusive license to use MorphoSys’s Slonomics technology. Financial and more precise timetable details of the deal were not…
-
Clinical Trial Tests New Cancer Radiation Treatment
A clinical study by Lawson Health Research Institute in London, Ontario, Canada is testing a new form of radiation therapy to treat cancerous tumors. The phase 2 trial aims to gauge effectiveness of stereotactic ablative radiotherapy or SABR on cancer patients in Canada and Europe. SABR delivers large concentrated doses of radiotherapy to precise areas,…
-
GSK, University of Dundee Partner on Huntington’s Disease
University of Dundee in Scotland and the pharmaceutical company GlaxoSmithKline (GSK) will collaborate in research to tackle Huntington’s disease, an inherited brain disorder. The joint project is valued at more than £1 million ($US 1.6 million). Dundee medical professor Susann Schweiger, who has discovered a mechanism that controls production of the disease-causing protein involved in…